Trials / Completed
CompletedNCT00441064
Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren
A Randomized, Open-label, Blinded Endpoint, Multi-center, Cross-over Study to Evaluate the Effect of High and Low Sodium Diets on Reduction in Mean 24-hour Ambulatory Blood Pressure in Systolic Hypertensive Patients Treated With Aliskiren (300 mg)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the effects of high and low level sodium (salt) diets on blood pressure in patients with hypertension (high blood pressure) who are taking aliskiren 300 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aliskiren |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2007-02-28
- Last updated
- 2011-03-25
- Results posted
- 2011-03-25
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00441064. Inclusion in this directory is not an endorsement.